These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
467 related articles for article (PubMed ID: 19386349)
1. CCND1 rearrangements and cyclin D1 overexpression in renal oncocytomas: frequency, clinicopathologic features, and utility in differentiation from chromophobe renal cell carcinoma. Sukov WR; Ketterling RP; Lager DJ; Carlson AW; Sinnwell JP; Chow GK; Jenkins RB; Cheville JC Hum Pathol; 2009 Sep; 40(9):1296-303. PubMed ID: 19386349 [TBL] [Abstract][Full Text] [Related]
2. Insertion (8;11) in a renal oncocytoma with multifocal transformation to chromophobe renal cell carcinoma. Salido M; Lloreta J; Melero C; García M; Placer J; Espinet B; Villa O; Bielsa O; Gelabert-Mas A; Serrano S; Solé F Cancer Genet Cytogenet; 2005 Dec; 163(2):160-3. PubMed ID: 16337860 [TBL] [Abstract][Full Text] [Related]
3. Renal oncocytomas with 11q13 rearrangements: cytogenetic, molecular, and immunohistochemical analysis of cyclin D1. Jhang JS; Narayan G; Murty VV; Mansukhani MM Cancer Genet Cytogenet; 2004 Mar; 149(2):114-9. PubMed ID: 15036886 [TBL] [Abstract][Full Text] [Related]
4. Cyclin D1 expression in renal carcinomas and oncocytomas: an immunohistochemical study. Lin BT; Brynes RK; Gelb AB; McCourty A; Amin MB; Medeiros LJ Mod Pathol; 1998 Nov; 11(11):1075-81. PubMed ID: 9831205 [TBL] [Abstract][Full Text] [Related]
5. Renal oncocytomas with rearrangements involving 11q13 contain breakpoints near CCND1. Zanssen S; Gunawan B; Fuzesi L; Warburton D; Schon EA Cancer Genet Cytogenet; 2004 Mar; 149(2):120-4. PubMed ID: 15036887 [TBL] [Abstract][Full Text] [Related]
6. Differential expression of KAI1 metastasis suppressor protein in renal cell tumor histological subtypes. Kauffman EC; Barocas DA; Chen YT; Yang XJ; Scherr DS; Tu JJ J Urol; 2009 May; 181(5):2305-11. PubMed ID: 19303095 [TBL] [Abstract][Full Text] [Related]
7. C-kit expression in renal oncocytomas and chromophobe renal cell carcinomas. Huo L; Sugimura J; Tretiakova MS; Patton KT; Gupta R; Popov B; Laskin WB; Yeldandi A; Teh BT; Yang XJ Hum Pathol; 2005 Mar; 36(3):262-8. PubMed ID: 15791570 [TBL] [Abstract][Full Text] [Related]
8. Renal cell neoplasms of oncocytosis have distinct morphologic, immunohistochemical, and cytogenetic profiles. Gobbo S; Eble JN; Delahunt B; Grignon DJ; Samaratunga H; Martignoni G; Zhang S; Wang M; Brunelli M; Cossu-Rocca P; Cheng L Am J Surg Pathol; 2010 May; 34(5):620-6. PubMed ID: 20305535 [TBL] [Abstract][Full Text] [Related]
9. DOG1, cyclin D1, CK7, CD117 and vimentin are useful immunohistochemical markers in distinguishing chromophobe renal cell carcinoma from clear cell renal cell carcinoma and renal oncocytoma. Zhao W; Tian B; Wu C; Peng Y; Wang H; Gu WL; Gao FH Pathol Res Pract; 2015 Apr; 211(4):303-7. PubMed ID: 25596994 [TBL] [Abstract][Full Text] [Related]
10. Chromosomal translocations involving 11q13 contribute to cyclin D1 overexpression in squamous cell carcinoma of the head and neck. Akervall J; Borg A; Dictor M; Jin C; Jin Y; Tanner M; Isola J; Mertens F; Wennerberg J Int J Oncol; 2002 Jan; 20(1):45-52. PubMed ID: 11743641 [TBL] [Abstract][Full Text] [Related]
11. The genetics of renal oncocytosis: a possible model for neoplastic progression. Al-Saleem T; Cairns P; Dulaimi EA; Feder M; Testa JR; Uzzo RG Cancer Genet Cytogenet; 2004 Jul; 152(1):23-8. PubMed ID: 15193438 [TBL] [Abstract][Full Text] [Related]
12. Chromosome 1 analysis in chromophobe renal cell carcinomas with tissue microarray (TMA)-facilitated fluorescence in situ hybridization (FISH) demonstrates loss of 1p/1 which is also present in renal oncocytomas. Meyer PN; Cao Y; Jacobson K; Krausz T; Flanigan RC; Picken MM Diagn Mol Pathol; 2008 Sep; 17(3):141-4. PubMed ID: 18382368 [TBL] [Abstract][Full Text] [Related]
13. Eosinophilic and classic chromophobe renal cell carcinomas have similar frequent losses of multiple chromosomes from among chromosomes 1, 2, 6, 10, and 17, and this pattern of genetic abnormality is not present in renal oncocytoma. Brunelli M; Eble JN; Zhang S; Martignoni G; Delahunt B; Cheng L Mod Pathol; 2005 Feb; 18(2):161-9. PubMed ID: 15467713 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic usefulness of fluorescent cytogenetics in differentiating chromophobe renal cell carcinoma from renal oncocytoma: a validation study combining metaphase and interphase analyses. Brunelli M; Delahunt B; Gobbo S; Tardanico R; Eccher A; Bersani S; Cossu-Rocca P; Parolini C; Balzarini P; Menestrina F; Cheng L; Eble JN; Martignoni G Am J Clin Pathol; 2010 Jan; 133(1):116-26. PubMed ID: 20023267 [TBL] [Abstract][Full Text] [Related]
15. Papillary renal cell carcinoma within a renal oncocytoma: case report of an incidental finding of a tumour within a tumour. Rowsell C; Fleshner N; Marrano P; Squire J; Evans A J Clin Pathol; 2007 Apr; 60(4):426-8. PubMed ID: 17405978 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of cytokeratin 7 and parvalbumin in differentiating chromophobe renal cell carcinoma from renal oncocytoma. Adley BP; Papavero V; Sugimura J; Teh BT; Yang XJ Anal Quant Cytol Histol; 2006 Aug; 28(4):228-36. PubMed ID: 16927643 [TBL] [Abstract][Full Text] [Related]
17. Expression of kidney-specific cadherin in chromophobe renal cell carcinoma and renal oncocytoma. Adley BP; Gupta A; Lin F; Luan C; Teh BT; Yang XJ Am J Clin Pathol; 2006 Jul; 126(1):79-85. PubMed ID: 16753598 [TBL] [Abstract][Full Text] [Related]
18. A collision tumor of papillary renal cell carcinoma and oncocytoma: case report and literature review. Goyal R; Parwani AV; Gellert L; Hameed O; Giannico GA Am J Clin Pathol; 2015 Nov; 144(5):811-6. PubMed ID: 26486747 [TBL] [Abstract][Full Text] [Related]
19. Review of renal oncocytoma with focus on clinical and pathobiological aspects. Kuroda N; Toi M; Hiroi M; Shuin T; Enzan H Histol Histopathol; 2003 Jul; 18(3):935-42. PubMed ID: 12792905 [TBL] [Abstract][Full Text] [Related]
20. FISH scoring on paraffin sections versus single-cell suspension for chromophobe renal carcinoma and renal oncocytoma. Brunelli M; Segala D; Delahunt B; Parolini C; Bersani S; Cheng L; Eble JN; Chilosi M; Gobbo S; Martignoni G Anticancer Res; 2011 Oct; 31(10):3137-42. PubMed ID: 21965719 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]